Related references
Note: Only part of the references are listed.Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India
Sunil S. Solomon et al.
PLOS ONE (2016)
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
Mark Sulkowski et al.
LANCET (2015)
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
Eric Lawitz et al.
LANCET (2015)
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study
Sunil Suhas Solomon et al.
LANCET INFECTIOUS DISEASES (2015)
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
M. P. Curry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
G. R. Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients
F. A. Gonzalez et al.
HIV MEDICINE (2015)
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis
Daniel J. Smith et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2015)
Examining non-AIDS mortality among people who inject drugs
Bradley M. Mathers et al.
AIDS (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Mark S. Sulkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treating Hepatitis C in Lower-Income Countries
Channa R. Jayasekera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis
Praveen Sharma et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2014)
Mortality among people who inject drugs: a systematic review and meta-analysis
Bradley M. Mathers et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B
Rohit Goyal et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Stability of liver fibrosis among HCV-infected injection drug users
Shruti H. Mehta et al.
ANTIVIRAL THERAPY (2012)
Normal liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country
Kausik Das et al.
HEPATOLOGY (2012)
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
William Sievert et al.
LIVER INTERNATIONAL (2011)
Chronic Hepatitis C Infection
Hugo R. Rosen
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Low Incidences of Human Immunodeficiency Virus and Hepatitis C Virus Infection and Declining Risk Behaviors in a Cohort of Injection Drug Users in Chennai, India
Sunil Suhas Solomon et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Mortality among injection drug users in Chennai, India (2005-2008)
Sunil S. Solomon et al.
AIDS (2009)
Assessment of Liver Fibrosis by Transient Elastography in Persons with Hepatitis C Virus Infection or HIV-Hepatitis C Virus Coinfection
Gregory D. Kirk et al.
CLINICAL INFECTIOUS DISEASES (2009)
What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
Alfredo Alberti
LIVER INTERNATIONAL (2009)
High Prevalence of HIV, HIV/Hepatitis C Virus Coinfection, and Risk Behaviors Among Injection Drug Users in Chennai, India: A Cause for Concern
Sunil S. Solomon et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Environmental factors as disease accelerators during chronic hepatitis C
Ariane Mallat et al.
JOURNAL OF HEPATOLOGY (2008)
Transient elastography: A new noninvasive method for assessment of hepatic fibrosis
L Sandrin et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2003)
Share Paper
